The phrase "administered a relatively" is correct and usable in written English.
It can be used in contexts where you are discussing the administration of something, such as a treatment, program, or policy, and want to indicate that it was done to a moderate or lesser degree.
Example: "The researchers administered a relatively low dose of the medication to assess its effects on the participants."
Alternatives: "administered a moderate" or "administered a lesser".
Twenty healthy volunteers were administered a relatively low dose of LSD.
I have reviewed cognitive training studies that administered a relatively heterogeneous battery of training tasks targeting different subcomponents of attentional control (e.g., Rueda et al., 2005; Wass et al., 2011) and others that administered more homogenous training targeting a single component of cognition (e.g., visuospatial working memory; Thorell et al., 2009).
The time-honored method of assessing preload responsiveness is to administer a relatively small intravascular volume bolus rapidly and observe the subsequent hemodynamic response in terms of blood pressure, pulse, cardiac output, SvO2 and related measures.
Specifically, in our study with rhesus monkeys, we were required to administer a relatively high (400 μg/kg) dBPA oral dose compared with predicted human BPA oral exposure of < 1 μg/kg/day to achieve serum concentrations similar to those reported in biomonitoring studies.
Reduction of fluid balance can be reasonably attributed to a shift in fluid management from the conventional method, in which large volumes of fluid are administered in a relatively fixed manner, to GDT, in which the administration of fluid is guided by SVV, a reliable predictor of fluid responsiveness [9].
However, only one dose was administered to a relatively small number of subjects.
Second, it can be administered in a relatively small space and is therefore easy to implement without extensive facilities.
CS is administered at a relatively low molecular weight (14 17 kDa), important for gastrointestinal absorption [ 44, 46], and is further depolymerized but not completely degraded [ 44, 47, 48].
Furthermore, it has been suggested that the lower but sustained anti-HCV activity of IFN- λ could be preferable, since IFN-based therapies are administered over a relatively long period.
The ideal drug would be effective against both early- and late-stage disease, orally administered over a relatively short course (i.e., 7 days), safe for all persons including children and pregnant women, and cost less than 30 euros per course.
